Tyropanoic acid: Difference between revisions
(Created page with "{{chembox | Verifiedfields = changed | verifiedrevid = 386052594 |ImageFile=Tyropanoate.png |ImageSize=200px | ImageFile1 = Tyropanoic acid 3D ball.png | ImageSize1 = 250 | Im...") |
No edit summary |
||
| Line 34: | Line 34: | ||
}} | }} | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Tyropanoic acid''' and its salt '''sodium tyropanoate''' are [[radiocontrast]] agents used in [[cholecystography]] ([[X-ray]] diagnosis of [[gallstone]]s). Trade names include Bilopaque, Lumopaque, Tyropaque, and Bilopac.<ref>{{cite web|url=http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=5611|title=PubChem CID 5611}}</ref> The molecule contains three heavy [[iodine]] atoms which obstruct X-rays in the same way as the calcium in bones to produce a visible image. After injection it is rapidly excreted into the [[bile]].<ref>{{cite journal | doi = 10.1172/JCI109755 | pmid = 7364937 | pmc=371433 | volume=65 | issue=5 | title=Inhibition of hepatic binding of thyroxine by cholecystographic agents |date=May 1980 | journal=J. Clin. Invest. | pages=1032–40}}</ref> | '''Tyropanoic acid''' and its salt '''sodium tyropanoate''' are [[radiocontrast]] agents used in [[cholecystography]] ([[X-ray]] diagnosis of [[gallstone]]s). Trade names include Bilopaque, Lumopaque, Tyropaque, and Bilopac.<ref>{{cite web|url=http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=5611|title=PubChem CID 5611}}</ref> The molecule contains three heavy [[iodine]] atoms which obstruct X-rays in the same way as the calcium in bones to produce a visible image. After injection it is rapidly excreted into the [[bile]].<ref>{{cite journal | doi = 10.1172/JCI109755 | pmid = 7364937 | pmc=371433 | volume=65 | issue=5 | title=Inhibition of hepatic binding of thyroxine by cholecystographic agents |date=May 1980 | journal=J. Clin. Invest. | pages=1032–40}}</ref> | ||
==References== | ==References== | ||
{{Reflist|2}} | |||
{{Contrast media}} | {{Contrast media}} | ||
| Line 44: | Line 48: | ||
[[Category:Organoiodides]] | [[Category:Organoiodides]] | ||
[[Category:Carboxylic acids]] | [[Category:Carboxylic acids]] | ||
[[Category: | [[Category:Drug]] | ||
Revision as of 13:54, 14 April 2015
| |
| |
| Names | |
|---|---|
| IUPAC name
2-[(3-butanamido-2,4,6-triiodophenyl)methyl]butanoic acid
| |
| Other names
2-[[2,4,6-triiodo-3-(1-oxobutylamino)phenyl]methyl]butanoic acid
| |
| Identifiers | |
3D model (JSmol)
|
|
| ChEMBL | |
| ECHA InfoCard | Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). |
PubChem CID
|
|
| |
| Properties | |
| C15H18I3NO3 | |
| Molar mass | 641.02 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
 verify (what is  ?)
| |
| Infobox references | |
|
WikiDoc Resources for Tyropanoic acid |
|
Articles |
|---|
|
Most recent articles on Tyropanoic acid Most cited articles on Tyropanoic acid |
|
Media |
|
Powerpoint slides on Tyropanoic acid |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Tyropanoic acid at Clinical Trials.gov Trial results on Tyropanoic acid Clinical Trials on Tyropanoic acid at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Tyropanoic acid NICE Guidance on Tyropanoic acid
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Tyropanoic acid Discussion groups on Tyropanoic acid Patient Handouts on Tyropanoic acid Directions to Hospitals Treating Tyropanoic acid Risk calculators and risk factors for Tyropanoic acid
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Tyropanoic acid |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Tyropanoic acid and its salt sodium tyropanoate are radiocontrast agents used in cholecystography (X-ray diagnosis of gallstones). Trade names include Bilopaque, Lumopaque, Tyropaque, and Bilopac.[1] The molecule contains three heavy iodine atoms which obstruct X-rays in the same way as the calcium in bones to produce a visible image. After injection it is rapidly excreted into the bile.[2]
References
- ↑ "PubChem CID 5611".
- ↑ "Inhibition of hepatic binding of thyroxine by cholecystographic agents". J. Clin. Invest. 65 (5): 1032–40. May 1980. doi:10.1172/JCI109755. PMC 371433. PMID 7364937.
- Pages with script errors
- Articles without InChI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without UNII source
- Chemical articles with unknown parameter in Chembox
- Articles with changed EBI identifier
- ECHA InfoCard ID from Wikidata
- Articles containing unverified chemical infoboxes
- Chembox image size set
- Organoiodides
- Carboxylic acids
- Drug